Larvol Delta - BBOT-Presents-Preclinical-Data-Demonstrating-panKRAS-Inhibitor-BBO11818-Has-Robust-AntiTumor-Activity-in-KRASMutant-Preclinical-Models-at-the-AACR-Annual-Meeting-2026

BBO-11818 - BridgeBio Oncology Therapeutics

https://www.globenewswire.com/news-release/2026/04/22/3279370/0/en/BBOT-Presents-Preclinical-Data-Demonstrating-pan-KRAS-Inhibitor-BBO-11818-Has-Robust-Anti-Tumor-Activity-in-KRAS-Mutant-Preclinical-Models-at-the-AACR-Annual-Meeting-2026.html

Apr 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next